With our brand-new patented antimicrobial technology...
FiteBac is dedicated to making the world a safer place.
Designed by Medical Professionals
Our antimicrobial technology can make what you make even better.
FiteBac is a Featured Presenter at IDS 2021
IDS is the leading global trade fair for the dental community
FiteBac was founded by a team of medical professionals and international researchers dedicated to improving lives with antimicrobial technology.
FiteBac® Proprietary Antimicrobial Additives
Antimicrobial Dental Products
Research & Development
FiteBac Skin Care
FiteBac Press Releases
FiteBac, manufacturer of patented antimicrobial compounds and additives for dentistryand medicine, announces partnership with RDAbbott to provide non-leaching, durableand persistent bactericidal, fungicidal, and virucidal protection in synthetic and siliconerubbers....
FiteBac Technology and Siltech team up to manufacture novel antimicrobial silsesquioxanes with advanced properties.
Summary: After the successful launch of multiple FDA-cleared antimicrobial dental devices, FiteBac partners with Siltech, an international corporation specializing in innovative silicone products, to develop novel materials imbued with FiteBac’s broad antimicrobial...
U.S.-Based FiteBac Presents in Germany for First Time at International Dental Show, IDS2021, to Feature New Antimicrobial Additives for Dental Restorative MaterialsSummary: FiteBac will be a new, featured presenter at the world’s largest dental conference, IDS 2021,...
Discover the versatility of FiteBac®
FiteBac® is a versatile antimicrobial technology, developed by Dr Kirk Kimmerling and Dr Franklin Tay, in collaboration with researchers from around the world, allowing for the incorporation of antimicrobial protection into almost any material.
By linking potent quaternary ammonium antimicrobials to a polymerizable silane backbone, they have developed a versatile new class of antimicrobial compounds that can be permanently incorporated into most materials.
Peer-reviewed scientific publications, as well as the recent clearance of K18 QAMS by the FDA for use in the manufacturing of dental acrylics, show the efficacy of the FiteBac® approach.